Abstract 7458: Germline-p53-mutant adrenocortical carcinoma is a possible candidate for the novel use of arsenic trioxide as a first targeted anticancer therapy for Li-Fraumeni syndrome
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Neha Wali, Richard P. Owen, Curtis C. Harris, Xin Lu
Institutions: University of Oxford, National Institutes of Health
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631246